Works by Meneghini, Luigi


Results: 72
    1
    2
    3
    4
    5
    6
    7
    8

    The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes.

    Published in:
    2013
    By:
    • Meneghini, Luigi;
    • Atkin, Stephen L;
    • Gough, Stephen C L;
    • Raz, Itamar;
    • Blonde, Lawrence;
    • Shestakova, Marina;
    • Bain, Stephen;
    • Johansen, Thue;
    • Begtrup, Kamilla;
    • Birkeland, Kåre I;
    • NN1250-3668 (BEGIN FLEX) Trial Investigators
    Publication type:
    journal article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Insulin Degludec in Type 1 Diabetes.

    Published in:
    Diabetes Care, 2011, v. 34, n. 3, p. 661, doi. 10.2337/dc10-1925
    By:
    • BIRKELAND, KÅRE I.;
    • HOME, PHILIP D.;
    • WENDISCH, ULRICH;
    • RATNER, ROBERT E.;
    • JOHANSEN, THUE;
    • ENDAHL, LARS A.;
    • LYBY, KARSTEN;
    • JENDLE, JOHAN H.;
    • ROBERTS, ANTHONY P.;
    • DEVRIES, J. HANS;
    • MENEGHINI, LUIGI F.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents in routine clinical practice (在常规临床实践中使用口服降糖药治疗的2型糖尿病患者每日一次使用地特胰岛素治疗的安全性)

    Published in:
    Journal of Diabetes, 2014, v. 6, n. 3, p. 243, doi. 10.1111/1753-0407.12091
    By:
    • Ross, Stuart;
    • Dzida, Grzegorz;
    • Ji, Qiuhe;
    • Kaiser, Marcel;
    • Ligthelm, Robert;
    • Meneghini, Luigi;
    • Nazeri, Avideh;
    • Orozco ‐ Beltran, Domingo;
    • Pan, Changyu;
    • Svendsen, Anne Louise
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50